Purpose The aim of this systematic review and meta-analysis was to examine and assess
the basic demographic characteristics and prevalence of comorbidities in acute mesenteric …

Objective Endovascular and hybrid methods have been increasingly used to treat
mesenteric ischemia. However, the long-term outcomes and risk of symptom recurrence …

Background Acute superior mesenteric venous thrombosis (ASMVT) decreases junction-
associated protein expression and intestinal epithelial cell numbers, leading to intestinal …

Background Early systemic anticoagulation (SAC) is a common practice in acute necrotizing
pancreatitis (ANP), and its impact on in-hospital clinical outcomes had been assessed …

Objective Mesenteric venous thrombosis (MVT) is a rare cause of acute surgical abdomen,
with high mortality. The aim of this study was to analyze long-term outcomes and possible …

Objective Non-cirrhotic porto-mesenteric vein thrombosis (NC-PMVT) is a rare but severe
clinical condition. The study aims to assess the effectiveness and safety of transjugular …

Background Anticoagulant therapy with heparin is the first-line treatment for acute
mesenteric vein thrombosis and is effective in improving outcomes. Conversely, patients …

Background Superior mesenteric venous thrombosis (SMVT) is mostly treated with
anticoagulation therapy; however, SMVT can lead to irreversible bowel ischemia and …

Purpose To assess technical feasibility and safety of portal vein thrombectomy with suction
thrombectomy using a large-bore thrombectomy device for portomesenteric venous …

Objective This systematic review and meta-analysis evaluated the published data on the
efficacy and safety of therapies for superior mesenteric venous thrombosis (SMVT), aiming …